Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Skechers USA Unlikely To Raise Outlook Due To Eurozone Hurdles, Says Analyst

Published 19/04/2024, 18:44
© Reuters.  Skechers USA Unlikely To Raise Outlook Due To Eurozone Hurdles, Says Analyst

Benzinga - by Shivani Kumaresan, Benzinga Staff Writer.

Wedbush analyst Tom Nikic reiterated an Outperform rating on the shares of Skechers USA Inc (NYSE:SKX) with a price target of $68.

Nike Inc (NYSE:NKE) and Levi Strauss & Co (NYSE:LEVI) recently reported February-quarter results and both saw worsening EMEA trends sequentially, noted the analyst.

At over 20% of sales, Europe is a meaningful part of SKX’s business, and though the management has counted it in a conservative guidance, the macro challenges in Europe likely limit upside to the quarter and guidance, noted the analyst.

According to the analyst, strong demand trends, particularly among the new Slip-In innovation, 1H23 was an exceptionally strong period for the U.S. DTC.

With the trends moderating in 2H23, the analyst sees further normalization to mid-single-digit growth in the first quarter and the rest of the year.

Based on the strengthening of the U.S. dollar since SKX reported fourth-quarter results, the analyst estimates a net EPS headwind of $0.10-$0.15.

Though the near-term story looks challenging, compelling points for a bullish stance include a strong product-innovation-and-marketing engine, momentum in Asia, which is larger than Europe for SKX, recovery potential in the U.S. wholesale channel and a strong balance sheet.

Given a tougher macro environment, the analyst guesses a reiteration of guidance is the most likely scenario.

Price Action: SKX shares are trading lower by 0.33% at $56.67 on the last check Friday.

Photo via Wikimedia Commons

Latest Ratings for SKX

Jan 2022OTR GlobalDowngradesPositiveMixed
Jan 2022WedbushUpgradesNeutralOutperform
Nov 2021Argus ResearchDowngradesBuyHold
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.